Your search returned 13 results.

Results
	1.	Cetuximab plus pemetrexed as second-line therapy for fluorouracil-based pre-treated metastatic esophageal squamous cell carcinoma. [electronic resource] by Tian, Jing Shang, Ming Shi, Sheng-Bin Han, Yong Xu, Jun Producer: 20151217 In: Cancer chemotherapy and pharmacology vol. 76 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	[Effect of second-line treatment with capecitabine and thalidomide in patients with advanced pancreatic cancer]. [electronic resource] by Shi, Sheng-bin Ma, Ting-hang Tang, Xiao-yong Li, Chun-hua Producer: 20140127 In: Zhonghua zhong liu za zhi [Chinese journal of oncology] vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Effect of maintenance therapy with dendritic cells: cytokine-induced killer cells in patients with advanced non-small cell lung cancer. [electronic resource] by Shi, Sheng Bin Ma, Ting Hang Li, Chun Hua Tang, Xiao Yong Producer: 20121011 In: Tumori vol. 98 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	lncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the efficacy of GEM based chemotherapy in first-line treatment of pancreatic cancer patients. [electronic resource] by Wang, Cui-Juan Shi, Sheng-Bin Tian, Jing Xu, Jun Niu, Zuo-Xing Publication details: Oncotarget Nov 2017 In: Oncotarget vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Pemetrexed plus rituximab as second-line treatment for primary central nervous system lymphoma. [electronic resource] by Zhao, Hai-Tao Chen, Jing Shi, Sheng-Bin Tian, Jing Tao, Rong-Jie Producer: 20160126 In: Medical oncology (Northwood, London, England) vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	S-1 plus CIK as second-line treatment for advanced pancreatic cancer. [electronic resource] by Wang, Meng Shi, Sheng-bin Qi, Jie-lin Tang, Xiao-yong Tian, Jing Producer: 20140905 In: Medical oncology (Northwood, London, England) vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy. [electronic resource] by Wang, Yue-Shen Tian, Jing Han, Yong Han, Shu-Mei Shi, Sheng-Bin Producer: 20170314 In: Oncology research vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma. [electronic resource] by Zhang, Bin Li, Rui Chang, Chun-Xiao Han, Yong Shi, Sheng-Bin Tian, Jing Producer: 20160715 In: OncoTargets and therapy vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Phase II trial of capecitabine combined with thalidomide in second-line treatment of advanced pancreatic cancer. [electronic resource] by Shi, Sheng-bin Wang, Meng Niu, Zuo-xing Tang, Xiao-yong Liu, Quan-yun Producer: 20130429 In: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	MicroRNA 25, microRNA 145, and microRNA 210 as biomarkers for predicting the efficacy of maintenance treatment with pemetrexed in lung adenocarcinoma patients who are negative for epidermal growth factor receptor mutations or anaplastic lymphoma kinase translocations. [electronic resource] by Shi, Sheng-Bin Wang, Meng Tian, Jing Li, Rui Chang, Chun-Xiao Qi, Jie-Lin Producer: 20160802 In: Translational research : the journal of laboratory and clinical medicine vol. 170 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Efficacy of erlotinib plus dendritic cells and cytokine-induced killer cells in maintenance therapy of advanced non-small cell lung cancer. [electronic resource] by Shi, Sheng-Bin Tang, Xiao-Yong Tian, Jing Chang, Chun-Xiao Li, Pei Qi, Jie-Lin Producer: 20141203 In: Journal of immunotherapy (Hagerstown, Md. : 1997) vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Treatment of stage IIIb/IV non-small cell lung cancer with Pemetrexed plus Oxaliplatin after failure of Erlotinib as second-line treatment. [electronic resource] by Shi, Sheng-Bin Hu, Rong-Hang Qi, Jie-Lin Tang, Xiao-Yong Tian, Jing Li, Rui Chang, Chun-Xiao Producer: 20131025 In: Medical oncology (Northwood, London, England) vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Pemetrexed plus dendritic cells as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer who had treatment with TKI. [electronic resource] by Hu, Rong-Hang Shi, Sheng-Bin Qi, Jie-Lin Tian, Jing Tang, Xiao-Yong Liu, Guo-Fang Chang, Chun-Xiao Producer: 20150514 In: Medical oncology (Northwood, London, England) vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)